Biodesix is a lung cancer diagnostic solutions company. Working alongside clinicians and scientists, we boldly question the status quo and employ novel approaches to swiftly deliver actionable results. Our blood-based tests leverage genomics and proteomics to uncover individualized insights about tumor biology and the patient’s immune response. As a devoted partner, we strive to transform lung cancer care standards. By equipping clinicians with the right information at the right time, we empower personalized care for every patient. We take lung cancer personally. Mission: Our mission is to improve every patient's lung cancer care by empowering physicians with swift, comprehensive, and actionable insights.
51 to 200
TypeCompany - Public (BDSX)
Revenue$25 to $50 million (USD)
IndustryBiotech & Pharmaceuticals
CompetitorsUnknown
Founded2007